000			04163nam a22003855i 4500
001			82243
003			ES-MaUEC
005			20230207040403.0
007			cr nn 008mamaa
008			150212s2015 gw | s |||| 0|eng d
020			_a9783319125534
024	7		_a10.1007/978-3-319-12553-4 _2doi
050		4	_aRD651 _b2015 EB
245	1	0	_aComparative Effectiveness in Surgical Oncology : _bKey Questions and How to Answer Them _cedited by Karl Y. Bilimoria, Christina A. Minami, David M. Mahvi.
260			_aCham, Switzerland _bSpringer _c2015
300			_a1 recurso en línea (XV, 259 páginas) _b14 ilustraciones, 6 ilustraciones en color
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
490	0		_aCancer Treatment and Research _x0927-3042 _v164
505	0		_aApproaches to Answering Critical CER Questions -- Leveraging Comparative Effectiveness Research to Improve the Quality of Multidisciplinary Care for Breast Cancer Patients -- Comparative Effectiveness in Melanoma -- Comparative Effectiveness Research for Sarcoma -- Comparative Effectiveness in Thyroid Cancer -- Comparative Effectiveness in Head and Neck Malignancies -- Comparative Effectiveness Issues in Lung Cancer -- Comparative Effectiveness in Esophagogastric Cancer -- Comparative Effectiveness in Colon and Rectal Cancer -- Research Gaps in Pancreatic Cancer Research and Comparative Effectiveness Research Methodologies -- Comparative Effectiveness in Surgical Oncology: Hepatic Malignancies -- Comparative Effectiveness Research in Urologic Cancers -- Comparative Effectiveness Research in Gynecologic Oncology.
520	3		_aDespite tremendous recent advances in the treatment of most malignancies, there remain several critical questions for each cancer. This particularly true for the surgical management of solid-organ malignancies.Âïmparative effectiveness is a relatively new term which encompasses the age-old concepts of how best to treat cancer patients. Comparative effectiveness is defined as the direct comparison of healthcare interventions to determine which work best for which patients when considering the benefits and risks. The Institute of Medicine has defined comparative effectiveness research (CER) as the generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition or to improve the delivery of care. ÂÅR is certainly best done with well-conducted randomized controlled trials. Unfortunately, clinical trials are not always feasible owing to the impracticality of conducting the trial, the considerable cost, and the time required to complete the trial. These challenges are even more pronounced with respect to surgical treatment.Thus alternative approaches may need to be considered in order to address pressing questions in the care of the oncology patient. These approaches may include well-conducted retrospective cohort studies from cancer registries and other data sources, decision and cost-effectiveness analyses, and other novel methodologies. This book lays out the current critical questions for each major malignancy and proposes approaches to gain answers to these pressing questions.Â{u2802}Â{u2802}Â{uE000}
710	2		_aSpringerLink (Online service) _0Local _9106996
942			_2lcc _cLE
650		7	_aCáncer _xCirugía _2embne _9175031
650	1	7	_aSalud pública _2embne _9138408
700	1		_aBilimoria, Karl Y. _eeditor literario _0Local _995042
700	1		_aMinami, Christina A _eeditor literario _995043 _0Local
700	1		_aMahvi, David M _eeditor literario _995044 _0Local
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-12553-4 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
907			_a.b12908836 _b10-10-17 _c10-02-16
988			_aSpringer_Medicine_2015
998			_am _a_alco _a_vill _b - - _cm _dz _e- _feng _ggw _h0
945			_aRD651 .C667 2015 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11576510 _z06-04-17
999			_c82243 _d82243 _x1